Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Mitacs brings innovation to more people in more places across Canada and around the world.
Learn MoreWe work closely with businesses, researchers, and governments to create new pathways to innovation.
Learn MoreNo matter the size of your budget or scope of your research, Mitacs can help you turn ideas into impact.
Learn MoreThe Mitacs Entrepreneur Awards and the Mitacs Awards celebrate inspiring entrepreneurs and innovators who are galvanizing cutting-edge research across Canada.
Learn MoreDiscover the people, the ideas, the projects, and the partnerships that are making news, and creating meaningful impact across the Canadian innovation ecosystem.
Learn MoreThe molecular mechanisms responsible for the occurrence of metastatic cancer are beginning to be elucidated with the identification of key regulators. Increasing evidence points to tumor cell epithelial to mesenchymal transition (EMT) as an important contributing process to metastatic evolution. The identification of factors that are stimulated during EMT might provide the means to develop new drugs required to increase the effectiveness of current regimens and improve patient outcome. Alethia Biotherapeutics is developing its AB-16B5, a humanized monoclonal antibody that targets secreted clusterin, a protein that is stimulated during EMT and contributes to invasion of tumors cells. The treatment with a true inhibitor of EMT is predicted to increase the effectiveness of current therapy and decrease metastasis, which should result in improved patient survival. Alethia Biotherapeutics has recently completed a first-in-human Phase I study with AB-16B5 in patients with advanced carcinomas. The primary objective of the proposed project is to elaborate a Phase II clinical trial protocol to test the hypothesis that treatment with AB-16B5 in combination with docetaxel, a cytotoxic agent, will result in an increased response rate.
Grégoire Leclair
Elisabeth Viau
Alethia Biotherapeutics Inc
Pharmacy / Pharmacology
Pharmaceuticals
Université de Montréal
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.